silvia giordano
University of Turin
Turin, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Turin
Turin, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
VU Medical Center
Amsterdam, Netherlands
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Pisa
Pisa, Italy
Associate Editor
Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
AstraZeneca (United States)
Wilmington, United States
Associate Editor
Cancer Immunity and Immunotherapy
Department of Otorhinolaryngology, Head and Neck Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University, Munich
Munich, Germany
Associate Editor
Head and Neck Cancer
University of California, Los Angeles
Los Angeles, United States
Associate Editor
Surgical Oncology
University of Minnesota Health Sciences, University of Minnesota Medical Center
Minneapolis, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
University of Parma
Parma, Italy
Associate Editor
Cancer Immunity and Immunotherapy
University of Milano-Bicocca
Milan, Italy
Associate Editor
Neuro-Oncology and Neurosurgical Oncology
European Commission, Joint Research Centre (JRC)
Ispra, Italy
Associate Editor
Breast Cancer
Sant'Andrea University Hospital, Sapienza University of Rome
Rome, Italy
Associate Editor
Thoracic Oncology
Department of Life Sciences, School of Sciences, European University Cyprus
Nicosia, Cyprus
Associate Editor
Molecular and Cellular Oncology
Privolzhsky Research Medical University (PIMU)
Nizhny Novgorod, Russia
Associate Editor
Cancer Imaging and Image-directed Interventions
School of Medicine, Johns Hopkins University
Baltimore, United States
Associate Editor
Cancer Imaging and Image-directed Interventions
Medical University of Vienna
Vienna, Austria
Associate Editor
Breast Cancer
Icahn School of Medicine at Mount Sinai
New York, United States
Associate Editor
Cancer Immunity and Immunotherapy